Literature DB >> 27635695

SPATA2: New insights into the assembly of the TNFR signaling complex.

Lisa Schlicher1,2,3, Ulrich Maurer1,2,3.   

Abstract

Entities:  

Keywords:  CYLD; HOIP; LUBAC; NF-kB; SPATA2; TNF; apoptosis; ubiquitylation

Mesh：

Substances：

Year:  2016        PMID： 27635695      PMCID： PMC5270513          DOI： 10.1080/15384101.2016.1232090

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

2.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

3.  cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production.

Authors:  N Vanlangenakker; T Vanden Berghe; P Bogaert; B Laukens; K Zobel; K Deshayes; D Vucic; S Fulda; P Vandenabeele; M J M Bertrand
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

4.  SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.

Authors:  Lisa Schlicher; Manuela Wissler; Florian Preiss; Prisca Brauns-Schubert; Celia Jakob; Veronica Dumit; Christoph Borner; Joern Dengjel; Ulrich Maurer
Journal:  EMBO Rep       Date:  2016-07-25       Impact factor: 8.807

5.  SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.

Authors:  Sebastian A Wagner; Shankha Satpathy; Petra Beli; Chunaram Choudhary
Journal:  EMBO J       Date:  2016-06-15       Impact factor: 11.598

6.  HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death.

Authors:  Nieves Peltzer; Eva Rieser; Lucia Taraborrelli; Peter Draber; Maurice Darding; Barbara Pernaute; Yutaka Shimizu; Aida Sarr; Helena Draberova; Antonella Montinaro; Juan Pedro Martinez-Barbera; John Silke; Tristan A Rodriguez; Henning Walczak
Journal:  Cell Rep       Date:  2014-10-02       Impact factor: 9.423

7.  LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.

Authors:  Peter Draber; Sebastian Kupka; Matthias Reichert; Helena Draberova; Elodie Lafont; Diego de Miguel; Lisanne Spilgies; Silvia Surinova; Lucia Taraborrelli; Torsten Hartwig; Eva Rieser; Luigi Martino; Katrin Rittinger; Henning Walczak
Journal:  Cell Rep       Date:  2015-12-06       Impact factor: 9.423
  7 in total
  3 in total

1.  Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.

Authors:  Sara E Vazquez; Sabrina A Mann; Aaron Bodansky; Andrew F Kung; Zoe Quandt; Elise M N Ferré; Nils Landegren; Daniel Eriksson; Paul Bastard; Shen-Ying Zhang; Jamin Liu; Anthea Mitchell; Caleigh Mandel-Brehm; Brenda Miao; Gavin Sowa; Kelsey Zorn; Alice Y Chan; Chisato Shimizu; Adriana Tremoulet; Kara Lynch; Michael R Wilson; Olle Kampe; Kerry Dobbs; Ottavia M Delmonte; Luigi D Notarangelo; Jane C Burns; Jean-Laurent Casanova; Michail S Lionakis; Troy R Torgerson; Mark S Anderson; Joseph L DeRisi
Journal:  bioRxiv       Date:  2022-03-24

2.  Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.

Authors:  Verena Wieser; Irina Tsibulak; Christine Degasper; Hannah Welponer; Katharina Leitner; Walther Parson; Alain G Zeimet; Christian Marth; Heidelinde Fiegl
Journal:  Cancer Sci       Date:  2019-02-16       Impact factor: 6.716

Review 3.  The Many Roles of Ubiquitin in NF-κB Signaling.

Authors:  Gilles Courtois; Marie-Odile Fauvarque
Journal:  Biomedicines       Date:  2018-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.